7:00 AM - 8:00 AM Meet the Professor Breakfasts*
1. LASPGHAN - Estrategias nutricionales para promover salud en Insuficiencia Intestinal (en español)
Debora Duro, MD, MS, Broward Health, Fort Lauderdale FL
 
2. Customizing Pediatric Nutrition: Tips and Tricks for Children with Low Energy Needs and for those on Blenderized Tube Feeds
Catherine Larson-Nath, MD, University of Minnesota
Nicole Misner, MS, RD, USF Pediatric Gastroenterology, Hepatology, and Nutrition

3. Pharmacologic Therapy for MASLD
Phillipp Hartmann, MD, Rady Children's Hospital / University of California San Diego
Pushpa Sathya, MD, FRCPC, M.Sc, Janeway Children's Health Centre

4. Managing Elevated Liver Enzymes in Cystic Fibrosis: A Step-by-step approach
Daniel Leung, MD, Baylor College of Medicine-Texas Children's Houston, TX
Oriana Gema Vanegas Calderon, MD, University of Utah

5. The Claims Game: Mastering Billing, Coding & Insurance Hurdles
Maureen Kelly, RN, PNP, DNP, UNC-Chapel Hill
David Choi, PharmD, BCACP, University of Chicago
Brad Constant, MD, Children's Hospital Colorado

6. GLP-2 Analogs for Short Bowel Syndrome
Alexandra Carey, MD, Boston Children's Hospital
Charles Vanderpool, MD, Riley Hospital for Children

12. Complex GERD and Stricture Management 101
Julie Khlevner, MD, AGAF, NewYork Presbyterian Morgan Stanley Children's Hospital
Jessica Yasuda, MD, Boston Children's Hospital

8:00 AM - 10:00 AM - Plenary Session
Moderators: Vicky Ng, MD, FRCPC, The Hospital for Sick Children and Jeannie Huang, MD, MPH, Rady Children's Hospital/UCSD

8:00 AM  Introduction and Welcome
                 Vicky Ng, MD, FRCPC, The Hospital for Sick Children
8:05 AM  William F Balistreri Keynote Lecture 
               How AI is Reshaping Pediatric Gastroenterology
               John E. Pandolfino, MD, Northwestern Medicine
8:45 AM  Business Meeting
                 8:45 Am Report from President 
                 9:00 AM Report from Secretary/Treasurer 
                 9:05 AM JPGN/JPGN Reports 
                 9:15 AM NASPGHAN Foundation 
9:20 AM  Richard J. Grand and John B. Watkins Prize
                FGFBP1+ UPPER CRYPT STEM CELLS REGENERATE INJURED INTESTINAL EPITHELIUM
                Jonathan Miller, NewYork-Presbyterian Hospital
9:32 AM NED Talk - PedsGI-Palooza in Action: Frontline Wisdom from Field Luminaries
              Carlo DiLorenzo, MD, Nationwide Children's Hospital

10:00 AM - 10:30 AM Break in Exhibit Hall
                                     
This break is suppported in part by Mirum Pharmaceuticals

10:00 AM - 2:00 PM Exhibit Hall Open

10:30 AM - 12:00 PM - Concurrent Session I

GI Potpourri: From Celiac Disease to Cystic Fibrosis
Moderators: Jonathan E. Teitelbaum, MD, Monmouth Medical Center and Darla Shores, MD, PhD, Washington University School of Medicine

10:30 AM Cystic Fibrosis: The Evolution of GI Care in the Era of CFTR Modulators
                  Racha Khalaf, MD, MS, University of South Florida
                  Learning objectives:
  • Describe the historical and current gastrointestinal (GI) manifestations of cystic fibrosis (CF), with emphasis on their clinical burden
  • Evaluate emerging evidence on how CFTR modulators are changing the landscape of GI disease management in CF patients
  • Identify current gaps in GI care for people with CF, even in the era of highly effective modulator therapy
10:55 AM NASPGHAN Foundation/George Ferry Young Investigator Development Award 
                 Genetic Risk Profiles of Celiac Disease in Down Syndrome
                 Marisa Gallant Stahl, MD, MSCS, Children's Hospital Colorado
11:07 AM Crossroads Between Celiac Disease and Other Autoimmune Conditions
                  Daniel Mallon, MD, Cincinnati Children's Hospital Medical Center
11:32 AM VALIDATION OF URINARY FATTY ACID BINDING PROTEIN 2 (FABP2) AS A
                 NON-INVASIVE DIAGNOSTIC AND PROGNOSTIC BIOMARKER OF CELIAC
                 DISEASE: EVIDENCE FROM A LARGE PEDIATRIC COHORT
                 Nidhi Kapoor, PhD, Orlando Health

Precision Medicine and Novel Therapeutics
Moderators: Robert J. Shulman, MD, Baylor College of Medicine and Ann Scheimann, MD, MBA, The Johns Hopkins Hospital

10:30 AM Precision Child Health: Lesson from Monogenic Intestinal Disease
                 Aleixo Muise, MD PhD FRCPC, The Hospital for Sick Children
                 Learning objectives:
  • Review the causes of monogenic intestinal diseases
  • Determine the types of “omic” available to determine underlying pathways driving intestinal disease
  • Understand how this omic information may lead to better treatments for intestinal diseases
10:55 AM NASPGHAN Foundation/QOL  Research Award for the Study of Disorders Associated
                  
with Carbohydrate Maldigestion/Malabsorption in Children 
                  
Leveraging Microbial Pharmacodynamic Biomarkers to Guide Precision Dosing for
                  Children with Crohn's Disease
                  Ruben Colman, MD, PhD, Stanford Medicine Children’s Health Center
11:07 AM Gene Targeted Therapy for Pediatric Liver and Metabolic Disease
                  Lorenzo D'Antiga, MD, FEBT, Hospital Papa Giovanni XXIII, Bergamo
11:32 AM COMPREHENSIVE PROTEOMIC EVALUATION TO IDENTIFY NOVEL PLASMA PROTEINS
                 ASSOCIATED WITH ENDOSCOPIC ACTIVITY IN PEDIATRIC CROHN'S DISEASE
                 Thomas Aviles, MD, Cincinnati Children's Hospital Medical Center

Advancing Care in Pediatric Liver Disease: PSC, Nutrition and Transplantation

Moderators: Nitika Gupta, MBBS, DCH, DNB, MRCP, Emory University and Robert Venick, MD, UCLA

10:30 AM The Many Faces of PSC: From Small to Large Duct and Everything in Between
                  Leina Alrabadi, MD, Stanford Medicine Children’s Health Center
                  Learning objectives:
  • Review the pathophysiology and natural history of primary sclerosing cholangitis (PSC), including implications for disease progression
  • Identify the diagnostic criteria and key phenotypic variations of PSC, with emphasis on clinical, radiologic, and histologic features
  • Discuss current management strategies for PSC, including medical and endoscopic therapies, application of prognostic tools, and indications for liver transplantation referral
  • Highlight emerging therapies and ongoing research in PSC, with a focus on clinical trials, novel biomarkers, and future directions in disease monitoring and treatment
10:55 AM NASPGHAN Foundation Mid-Level Career Development Award
                  Living Donor Liver Transplant: Is It a Cost-Effective Option for Children in 
                  Need of Transplantation
                  Amy Feldman, MD, Children's Hospital Colorado
11:07 AM Optimizing Nutrition in Cholestatic Liver Disease: A Collaborative Approach
                  Rima Fawaz, MD, Yale University and Lauren Storch, MS, RD, CSP, LD, Nationwide
                  Children's Hospital
                  Learning objectives:
  • Understand the pathophysiology of nutritional deficiencies and sarcopenia in cholestatic liver disease
  • Assess nutritional status of children with cholestatic liver disease
  • Describe a practical approach for surveillance and supplementation
11:32 AM Gerard Odell Prize for Excellence in Liver Research
                 NOVEL POINT-OF-CARE DIAGNOSTIC RISK MODEL AND CLINICAL CALCULATOR
                 FOR BILIARY ATRESIA
                 Sandra Rios-Melendez, MD, The University of Texas Southwestern Medical Center

Health Equity Rounds: A Case-Based Approach to Feeding Disorders
Moderators: Dennis Spencer, MD, PhD, Boston Children's Hospital and Conrad Cole, MD, MPH, MSc, University of Florida

10:30 AM Intro to Health Equity Grand Rounds
                  Jason (Yanjia) Zhang, MD, PhD, Boston Children's Hospital
                 Panel:
  • Peace Nkechinyere Dike, MD, Lucile Packard Children's Hospital / Stanford
  • Alan Silverman, PhD, Medical College of Wisconsin          
  • Venus S. Kalami, MNSP, RD, CSP, Lucile Packard Stanford Children's Health
                 Learning objectives:
  • Identify the psychological and sociocultural factors contributing to disparities in the diagnosis and treatment of pediatric feeding disorders across diverse populations
  • Apply a case-based framework to recognize the impact of bias, systemic inequities, and social determinants of health on the assessment and management of feeding disorders from a psychological perspective
  • Develop interdisciplinary strategies grounded in culturally responsive care principles to promote equitable outcomes in children with feeding disorders


Motility Skills Workshop: Mapping Dysfunction, Restoring Function: Exploring the Role of Anorectal Manometry and Pelvic Floor Biofeedback Therapy

Moderators: Lusine Ambartsumyan, MD, Seattle Children's Hospital and Janice Bitong, MD, Medical College of Wisconsin

Presenters:

  • Khalil El-Chammas, MD, Cincinnati Children's Hospital
  • Corey Baker, MD, Connecticut Children's

12:00 PM – 2:00 PM Poster Session II

12:00 PM - 1:00 PM Lunch in Exhibit Hall

12:00 PM - 2:00 PM Hands on Endoscopy Course*
                                Skills available include:
  • Clipping
  • Polypectomy
  • Coagulation & APC (Argon Plasma Coagulation)
  • Topical Hemostasis
  • Balloon Enteroscopy

Hands on Endoscopy is supported in part by educational grants from: 3-D Matrix, Inc, Fuji, Olympus and Ovesco.

2:30 PM - 4:00 PM - Concurrent Session II

What to Do when You Get stuck: An Interdisciplinary Panel Discussion of Challenging Constipation Cases
Moderators: Lusine Ambartsumyan, MD, Seattle Children's Hospital and Rodrigo Vazquez Frias, Md, MsC, PhD, Hospital Infantil De México Federico Gómez

Panel:
  • Alexandra Kilgore, MD, Children's Hospital Colorado
  • Christina Low Kapalu, PhD, Oregon Health Science University
  • Richard J. Wood, MD, Nationwide Children's Hospital
  • Toni Solari, RD, LDN, Boston Children's Hospital
Learning objectives:
  • Discuss the role of diet in pediatric functional constipation
  • Identify barriers to treatment and the behavioral interventions necessary to implement effective treatment strategies in pediatric functional constipation
  • Review the medical management of pediatric functional constipation and therapy escalation in refractory constipation
  • Recognize the utility of diagnostic testing in the evaluation of refractory constipation
  • Understand the role of surgery in the management of pediatric refractory constipation
It Takes a Village: Addressing Liver Disease Together
Moderators: Pamela Valentino, MD, Seattle Children's Hospital and Sara Hassan, MD, University of Texas Southwestern (UTSW)

2:30 PM Fontan-Associated Liver Disease: Physiology and the Fight Against Progression
               Ryan Fischer, MD, Children's Mercy Kansas City
               Learning objectives:
  • Introduce Fontan-associated liver disease (FALD)
  • Understand pathophysiology behind development
  • Delineate best practices for monitoring
  • Discuss potential to ameliorate progression
2:55 PM Flash Abstracts
  • METABOLOMIC PROFILING IN GROWTH IMPAIRED PEDIATRIC LIVER TRANSPLANT RECIPIENTS
    Luis Lopez, MD, Northwestern University Feinberg School of Medicine
  • CHARACTERISTICS AND OUTCOMES OF FONTAN ASSOCIATED LIVER DISEASE IN CHILDREN FROM A MULTICENTER - INITIAL ANALYSIS OF 8 CENTERS IN USA
    Chaowapong Jarasvaraparn, MD, Riley Hospital for Children at Indiana University Health
  • MITOCHONDRIAL DNA CONTENT IN PERIPHERAL BLOOD CELLS AS A MARKER OF DISEASE PROGRESSION IN PEDIATRIC METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Joseph Chapman, MD, Children's Hospital at Montefiore
3:07 PM Balancing Hormonal Therapy and Liver Health in Adolescents with Chronic Liver Disease:
               A Combined Medical and Psychological Approach
               Jean Molleston, MD, Riley Hospital for Children and Jamie L. Ryan, PhD, Children's
               Mercy Kansas City
               Learning objectives:
  • Delineate pathophysiologic considerations in decision-making regarding birth control and hormonal therapy in patients with liver disease or liver tumors
  • Discuss risks and benefits of hormonal therapy with teenagers with chronic liver disease, transplant, or tumors
  • Explain the role and impact of shared decision-making on self-management in adolescents with chronic illness
  • Describe potential barriers and facilitators of shared decision-making in the context of hormonal therapy in adolescent liver disease
3:32 PM Fellow Research Award
              PEDIATRIC LIVER TRANSPLANT OUTCOMES AND THE ASSOCIATION WITH SOCIOECONOMIC
              STATUS: A POPULATION-BASED COHORT STUDY OVER 30 YEARS
              Toshifumi Yodoshi, MD, PhD, The Hospital for Sick Children

Cutting to the Core: Balancing Medicine Vs Surgery in Pediatric IBD
Moderators: Sabina Ali, MD, UCSF Benioff Children's Hospital and Shervin Rabizadeh, MD, Cedars-Sinai

2:30 PM OUTCOMES OF VEDOLIZUMAB THERAPY IN BIO-NAIVE VERSUS BIO-EXPOSED
              CHILDREN WITH INFLAMMATORY BOWEL DISEASE
              Casey Konys, MD, Ann & Robert H Lurie Children's Hospital of Chicago
2:37 PM NATIONAL TRENDS IN COLECTOMY RATES IN PEDIATRIC PATIENTS WITH ULCERATIVE
              COLITIS AND IBD-UNCLASSIFIED IN THE PRE AND POST BIOLOGIC ERA
              Emily Lai, MD, University of California San Francisco
2:44 PM One Patient, Many Perspectives: Multidisciplinary Insights - Medicine Vs Surgery in IBD 
              Panel:
  • Jennifer Dotson, MD, MPH, Arkansas Children's Hospital
  • Jennifer Strople, MD, Ann & Robert H. Lurie Children's Hospital
  • Lisa McMahon, MD, FACS, FAAP, Phoenix Children's Hospital
  • Jennie David, PhD, Nationwide Children's Hospital           
              Learning objectives:
  • Differentiate medical and surgical indications in pediatric IBD
    • Recognize when medical management may be optimized or exhausted, and when surgical intervention becomes necessary
  • Evaluate multidisciplinary decision-making in complex IBD care
    • Understand how perspectives from gastroenterology, surgery and other disciplines contribute to individualized treatment plans
  • Analyze disease phenotype and severity to guide management strategy
    • Identify clinical, endoscopic, and radiologic markers that influence choice between escalating medical therapy and surgical options
    • Explore communication strategies to involve families in shared decision-making, especially when weighing invasive options
    • Learn key elements of pre-surgical optimization, nutritional support, and post-surgical monitoring for complications and recurrence
Gutsy Innovations: Optimizing Intestinal Failure Care
Moderators: David Galloway, MD, University of Alabama At Birmingham and Farhana Ali-Geiger, MD, University of Utah, Primary Children's Hospital

2:30 PM Intestinal Failure Associated Liver Disease: Strategies to Protect the Liver
               Alexandra Carey, MD, Boston Children's Hospital
               Learning objectives
  • Describe the pathophysiology and risk factors contributing to the development of intestinal failure associated liver disease (IFALD) in pediatric patients
  • Identify early subclinical/clinical signs and diagnostic strategies for detecting liver dysfunction in children with intestinal failure
  • Evaluate current evidence-based strategies for protecting the liver and managing IFALD and its associated complications, including nutritional, pharmacologic, and surgical interventions
2:55 PM NASPGHAN Foundation/Abbott Nutrition Advanced Fellowship Training in Pediatric Nutrition
               Use of an In-Line Digestive Cartridge in Short Bowel Syndrome
               Elaine Lin, MD, Children's Hospital of Philadelphia
3:07 PM Smart Records, Smarter Care for Intestinal Failure
               Kerry Reed, MS, CPNP-PC, RN, Children’s Hospital Colorado and
               Mary Abigail Garcia, MD, University of California, San Diego
               Learning objectives:
  • Demonstrate how electronic medical documentation can be standardized and streamlined
  • Identify novel ways of obtaining data in a meaningful way to track patient characteristics, treatment and outcomes
3:32 PM AN INNOVATIVE DREAM PROMOTES INTESTINAL ADAPTATION AND PREVENTS
              LIVER INJURY IN SHORT BOWEL SYNDROME
              Shaurya Mehta, Saint Louis University School of Medicine

Advancing Pediatric GI Care: Research Abstracts Showcase
Moderators: Kathleen M. Loomes, MD, Children's Hospital of Philadelphia and Jennifer Woo Baidal, MD, MPH, Stanford University

2:30 PM NASPGHAN Neurogratroenterology and Motility Prize – Basic
               A LARGE-SCALE ELISA-BASED STUDY TO DETERMINE THE DIAGNOSTIC THRESHOLD
               OF HUMAN PEPSIN A AS A BIOMARKER OF MICROASPIRATION
               Nidhi Kapoor, PhD, Orlando Health
2:40 PM NASPGHAN Award for Advancing Equity for Women in Medicine
               THE CONTEXT DEPENDENT ROLE OF CELLULAR SENESCENCE IN BILIARY ATRESIA
               Katie Conover, MD, University of Colorado 
2:50 PM Young Faculty Investigator Award
               A NOVEL TRUNCATING EP300 MUTATION IMPAIRS INTESTINAL EPITHELIAL
               DIFFERENTIATION IN PATIENT TISSUE AND ORGANOIDS AND CAN BE RESCUED BY
               CHEMICAL HDAC INHIBITION
               Lauren Collen, MD, Boston Children's Hospital
3:00 PM Cyclic Vomiting Syndrome Association (CVSA) Young Investigator Prize in honor of B Li
               IMPACT OF APREPITANT USE ON LENGTH OF STAY AND REPEAT HOSPITALIZATION
               FOR CHILDREN WITH CYCLIC VOMITING SYNDROME
               Sergio Cobos, MD, Nationwide Children's Hospital
3:10 PM Feeding Matters Outstanding Pediatric Feeding Disorder Abstract Award
               SALIVARY SUBSTANCE P IS A SENSITIVE AND SPECIFIC BIOMARKER OF
               ASPIRATION IN INFANTS AND TODDLERS
               Daniel Duncan, MD, Boston Children's Hospital
3:20 PM ENTEROCYTES REGULATE HEPATIC BILE ACID SYNTHESIS IN CO-CULTURED GUT AND
              LIVER ORGANOIDS WITH INTERRUPTION UPON SIRNA TRANSFECTION
               Ashlesha Bagwe, MD, Saint Louis University School of Medicine
3:30 PM DECODING CILIARY DYSFUNCTION IN HEPATOBILIARY DEVELOPMENT:
              MECHANISTIC INSIGHTS INTO BILIARY ATRESIA PATHOGENESIS
               Prasanna Venkatesh Ramachandran, MD, PhD, Boston Children's Hospital 
3:40 PM Flash Abstracts
  • CHILDREN WITH ANTRAL HYPOMOTILITY OR SMALL BOWEL DYSMOTILITY HAVE A GREATER RESPONSE TO GASTRIC ELECTRICAL STIMULATION
    Eduardo Castillo Leon, MD, Nationwide Children's Hospital
  • PEDIATRIC-SPECIFIC HIGH-RESOLUTION ESOPHAGEAL MANOMETRY PROTOCOLS ARE ESSENTIAL: EVIDENCE FROM A MULTICENTER COHORT STUDY
    Trevor Davis, MD, Washington University School of Medicine
  • GASTRIC PERORAL ENDOSCOPIC MYOTOMY (GPOEM) PERFORMED BY A PEDIATRIC GASTROENTEROLOGIST IS SAFE AND EFFECTIVE IN THE TREATMENT OF PEDIATRIC GASTROPARESIS
    Ashley Croker-Benn, MPH, Boston Children's Hospital

Colonoscopy Skills Workshop*
Course Directors: Faith Ihekweazu, MD, Baylor College of Medicine and Catharine Walsh, MD, MEd, PhD, FRCPC, Hospital for Sick Children


4:15 PM – 6:00 PM  Awards Ceremony

6:00 PM - 8:00 PM - Sesión y Recepción de LASPGHAN (en español)
Moderadores: Jose  Garza, MD, Children's Center for Digestive Health Care & Rodrigo Vázquez Frias MD, MSc, PhD, Hospital Infantil de México Federico Gómez

 6:05 PM Descifrando el enigma de la EII de inicio muy temprano (VEO-IBD): cuando la inflamación comienza demasiado pronto
               Rodrigo Vázquez Frias MD, MSc, PhD, Hospital Infantil de México Federico Gómez
               Objetivos de aprendizaje:
  • Reconocer las características clínicas distintivas de la enfermedad inflamatoria intestinal de inicio muy temprano (VEO-IBD) y cómo difieren de formas de presentación en edades mayores
  • Explorar los desafíos diagnósticos asociados con VEO-IBD, incluyendo las limitaciones de los criterios tradicionales y la importancia del diagnóstico genético
  • Comprender los mecanismos inmunológicos y genéticos implicados, con énfasis en las mutaciones monogénicas y las alteraciones en la regulación inmunitaria
  • Discutir el papel de la nutrición en el manejo de pacientes con VEO-IBD, incluyendo el soporte nutricional, uso de dietas especializadas y consideraciones en casos con inmunodeficiencias asociadas
6:30 PM ¿Gastroparesia o síntomas similares a la gastroparesia? Aclarando una presentación clínica compleja
               Ricardo Arbizu, MD, MS, Baylor College of Medicine
               Objetivos de aprendizaje:
  • Delinear los síntomas superpuestos entre la gastroparesia y las condiciones similares a la gastroparesia
  • Analizar las diferentes herramientas diagnósticas para evaluar la función gástrica
  • Revisar las estrategias de tratamiento para la gastroparesia y los síntomas similares a la gastroparesia
7:00 PM Enfoque actual de la pancreatitis crónica pediátrica
               Maria Susana Lopez Gonzalez, MD, Baylor College of Medicine
               Objetivos de aprendizaje:
  • Comprender la fisiopatología y etiología de la pancreatitis crónica en pacientes pediátricos
  • Reconocer la presentación clínica y los criterios diagnósticos de pancreatitis crónica en la población pediátrica
  • Analizar el papel de las pruebas genéticas en la evaluación de niños con pancreatitis crónica
  • Describir estrategias de manejo basadas en la evidencia, incluyendo apoyo nutricional, manejo del dolor, reemplazo de enzimas pancreáticas y opciones quirúrgicas
  • Revisar los avances recientes y las terapias emergentes en el manejo de pancreatitis crónica pediátrica

7:50 PM ARE CHILDREN WITH CEREBRAL PALSY MORE LIKELY TO DEVELOP ESOPHAGITIS,
              REGARDLESS OF GASTROESOPHAGEAL REFLUX SYMPTOMS?
              Cecilia Zubiri, MD, HIAEP Sor Maria Ludovica

8:00 PM Reception

*Separately ticketed event.